Corrigendum to “Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]

The authors regret an error in Figure 1, whereby parts B and C of the figure should be reversed. The authors would like to apologise for any inconvenience caused.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Corrigendum Source Type: research